ro 31-8220 has been researched along with Chronic Disease in 2 studies
Ro 31-8220: a protein kinase C inhibitor
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Das, M | 1 |
Dempsey, EC | 1 |
Bouchey, D | 1 |
Reyland, ME | 1 |
Stenmark, KR | 1 |
Webster, NJ | 1 |
Vaughan, PF | 1 |
Peers, C | 1 |
2 other studies available for ro 31-8220 and Chronic Disease
Article | Year |
---|---|
Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase c isozymes.
Topics: Animals; Animals, Newborn; Cattle; Cell Division; Cells, Cultured; Chronic Disease; Enzyme Inhibitor | 2000 |
Hypoxic enhancement of evoked noradrenaline release from the human neuroblastoma SH-SY5Y.
Topics: Calcium; Cell Hypoxia; Chronic Disease; Electric Stimulation; Enzyme Inhibitors; Exocytosis; Humans; | 2001 |